The article discusses research on chelation therapy in patients with cardiovascular disease, published in a 2013 issue of the "Journal of the American Medical Association." Chelation therapy has been found to reduce metastatic calcium deposits. The primary outcome of the study included a composite of total mortality, recurrent myocardial infarction (MI), and stroke. According to the article, the results of the study did not demonstrate a benefit of chelation therapy.